Clinical trial
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results…
NCT00324467 · British Columbia Cancer Agency, Other · Unknown status
Key facts
| NCT number | NCT00324467 |
|---|---|
| Title | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment |
| Official title | Phase II Trial Investigating Tailoring First-Line Therapy For Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Based on Mid-Treatment Positron Emission Tomography (PET) Scan Results |
| Acronym | LYTPET |
| Lead sponsor | British Columbia Cancer Agency, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma |
| Intervention type | Drug, Other |
| Interventions | Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Ondansetron, Dexamethasone, Diphenhydramine, Acetaminophen, Ifosfamide, Mesna (IV) and 5 more |
| Enrollment | 150 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2021 |
| Completion | Dec 1, 2021 |
| First posted | May 11, 2006 |
| Last update posted | Jul 22, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: